Beacon Equity Research reports on the OTC and OTCBB Trade Leaders: Acura Pharmaceuticals, Inc. (OTCBB: ACPH), MSTI Holdings, Inc. (OTCBB: MSHI), Tower Tech Holdings Inc. (OTCBB: TWRT), Datameg Corp (OTCBB: DTMG), and American Medical Technologies ...

To sign up for our free research reports and newsletters, visit http://beaconequityresearch.com/. For more information on our research programs, please contact: Jeff Bishop at editor@beaconequityresearch.com

Acura Pharmaceuticals, Inc. (OTCBB: ACPH) Up 21.32% on Monday

Detailed quote: http://beaconequityresearch.com/ACPH

December 10, 2007 - Acura Pharmaceuticals, Inc. Announces Receipt of $30 Million Cash Payment and Closing of Agreement With King Pharmaceuticals

Acura Pharmaceuticals, Inc. (OTC Bulletin Board: ACPH) today announced the closing of the License, Development and Commercialization Agreement (the "Agreement") with King Pharmaceuticals Research and Development, Inc., a subsidiary of King Pharmaceuticals, Inc. ("King") and receipt of the initial $30 million non- refundable cash payment from King under the Agreement. The Agreement closing was subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act which was received December 6, 2007. Upon the closing of the Agreement, the Company paid off its $5 million secured term note in accordance with the Agreement and the prepayment provisions of the secured term note. The Company now has no term debt on its balance sheet.

The Agreement provides King with an exclusive license in the United States, Canada, and Mexico (the "Territory") for ACUROX(TM) Tablets plus another undisclosed opioid product candidate utilizing Acura's Aversion(R) Technology. In addition, the Agreement provides King with an option to license in the Territory all future opioid analgesic products developed utilizing Acura's Aversion(R) Technology. In addition to the $30 million initial payment announced today, Acura could also receive additional cash payments from King of up to $28 million for ACUROX(TM) Tablets and similar amounts with respect to each future product licensed based on successful achievement of certain development and regulatory milestones specified in the Agreement. King will reimburse Acura for all ACUROX(TM) Tablet research and development expenses incurred beginning from September 19, 2007 and all research and development expenses related to future products after King's exercise of its option to an exclusive license for each future product. King will record net sales of all products and pay Acura a royalty ranging from 5% to 25% based on the level of combined annual net sales for all products subject to the Agreement. King will also make a one-time cash payment to Acura of $50 million in the first year in which the combined annual net sales of all licensed products exceed $750 million.

MSTI Holdings, Inc. (OTCBB: MSHI) Up 5.26% on Monday

Detailed quote: http://beaconequityresearch.com/MSHI

December 10, 2007 - MSTI Applauds FCC Decision to Encourage Competition

MSTI Holdings, Inc. (OTCBB: MSHI), a carrier class communications technology company specializing in providing true quad play services to residential, hospitality and commercial properties, announced today that its wholly-owned subsidiary, Microwave Satellite Technologies, Inc. (MST, Inc./NuVisions), joins consumers and other technology innovators in applauding the recent Federal Communications Commission (FCC) decision. The decision denied Verizon's forbearance petitions that sought to eliminate pro-competitive rules in six major East Coast markets affecting 34 million Americans. By denying the petitions, the FCC acted to protect competitive choice in the Boston, MA, Providence, RI, New York City, NY, Virginia Beach, VA and Philadelphia and Pittsburgh, PA markets.

"The FCC's denial continues to advance consumer choice and spurs price competition for the benefit of telecommunications users. Verizon remains obligated by law to provide unbundled network elements at regulated prices to competitors in several densely populated metropolitan service areas, including New York City and New Jersey where MST operates," said Frank T. Matarazzo, CEO, Microwave Satellite Technologies, Inc.

"If Verizon's forbearance request had been granted, it likely would have been too costly for us to obtain the required unbundled network elements to access its networks." We likewise commend Chairman Martin and the Commissioners for initiating a review of the FCC's forbearance process. Reevaluating and developing relevant rules and procedures to govern the consideration of forbearance petitions going forward will propel competition nationwide," added Matarazzo.

Tower Tech Holdings Inc. (OTCBB: TWRT) Up 18.95% on Monday

Detailed quote: http://beaconequityresearch.com/TWRT

December 10, 2007 - Tower Tech Holdings Inc. to Acquire Energy Maintenance Service, LLC

Tower Tech Holdings Inc. (OTC:TWRT) announced today that it has signed a definitive agreement to acquire Energy Maintenance Service, LLC, a Gary, South Dakota-based full service provider to the wind industry. EMS's offerings include construction, operations and maintenance and component repairs.

"With the acquisition of EMS, our customer portfolio will expand to include major wind turbine manufacturers which represent a majority of the North American market," said Cam Drecoll, CEO of Tower Tech. Drecoll added, "EMS's integrated service approach to wind customers is well-recognized in the industry and will serve as a springboard to further opportunities for Tower Tech."

"Tower Tech is on track to become the premier provider of components and services to the wind energy industry," said Joe Kolbach, President and Majority Owner of Energy Maintenance Service. He continued, "I believe this transaction and our planned joint initiatives will greatly benefit our customers, employees, communities and shareholders. We look forward to further announcements regarding additional locations and service offerings which are now possible through our partnership with Tower Tech. Tower Tech's management philosophy matches up very well with that of EMS regarding employees, allowing us to continue our commitment to advancing employee career growth through extensive training and development programs."

EMS is a full service provider to the wind energy industry with over 170 employees throughout the United States. EMS offers operations services which include engineering and construction, training and wind farm management. EMS also offers repair and retrofit services, including gear box, blade and other component repairs. EMS is led by Joe Kolbach, who will continue as part of the leadership team at Tower Tech after the closing of the transaction.

The terms of the transaction will be available on a separate form 8-K filed with the SEC. The transaction is expected to close by the first quarter of 2008.

Datameg Corp (OTCBB: DTMG) Up 33.33% on Monday

Detailed quote: http://beaconequityresearch.com/DTMG

December 10, 2007 - Datameg Completes Acquisition of American Marketing & Sales Inc. D/B/A Innovative Designs

Datameg Corp (OTCBB: DTMG) today announced it has completed the acquisition of American Marketing & Sales Inc. D/B/A Innovative Designs. Datameg announced in August that it had entered into an agreement to acquire the company for 15 million unregistered shares of Datameg common stock.

American Marketing & Sales, a $10 million company that markets finished food packaging products nationwide to major supermarkets and food retailers, will be operated as a wholly-owned subsidiary of Datameg. The company expects to close the previously-announced acquisition of Computer Ctr.com in January 2008.

Datameg also announced that it will report pro-forma fiscal year 2007 results that will include the addition of American Marketing and Sales financials.

Founded in 1999 in Leominster, Mass. by Leonard J. Tocci, American Marketing & Sales Inc. had 2006 revenues of just under $10 million and annual growth of 15 to 20 percent in the past three years. Mr. Tocci remains with Datameg as President of American Marketing and Sales and as a member of the senior management team of Datameg.

"When we report our numbers next year, we believe people will agree that we're a new Datameg" said Jim Murphy, Datameg CEO. "With this firm financial foundation, we expect to be able to report continued progress in our aim of creating a dynamic company."

In the company's 10QSB for the third quarter, Datameg's wholly-owned subsidiary Net Symphony discussed plans for delivery in December 2007 of a working prototype based on plans and engineering designs developed in the second and third quarters of 2007. That delivery appears to be on schedule.

American Medical Technologies Inc. (OTCBB: ADLI) Up 12.50% on Monday

Detailed quote: http://beaconequityresearch.com/ADLI

December 10, 2007 - American Medical Technologies, Inc. Announces Partnership with Discus Dental to be the Authorized Representative of BriteSmile(R) and BreathRx(R) Products in International Markets

Consistent with its core strategic initiative of acquiring and selling quality dental and medical products through its international distribution network, American Medical Technologies Inc. (AMT) (OTCBB:ADLI) is pleased to announce the development of a global partnership with Discus Dental. Under the terms of this agreement AMT will act as international sales representative for the BriteSmile(R) brand of professional tooth whitening products as well as the BreathRx(R) brand of professional oral care products throughout the world.

"AMT has a successful sales track record in the global tooth whitening and oral care markets and is well-suited to carry out the distributor sales and service functions that these product lines require," says Todd Cooper, Executive SVP Global Sales & Marketing at Discus Dental.

"AMT's presence and influence in the global dental market is growing stronger," says Judd D. Hoffman, President and CEO of AMT. "BriteSmile and BreathRx are two phenomenal brands which are market leaders in the Professional Tooth Whitening and Breath Care markets respectively. We believe that by leveraging our international experience we will maximize global sales for both brands and deliver more revenue and profit to our bottom line. We are thrilled to align ourselves with Discus Dental and to provide them with a team that will grow the BriteSmile and BreathRx names to levels warranted by such their product excellence and resulting market stature."

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN THIS DOCUMENT. ALL INFORMATION PROVIDED HERE IS MERELY INFORMATIONAL AND IS NOT INTENDED TO BE A RECOMMENDATION TO BUY OR SELL ANY SECURITY. YOU SHOULD CONSULT A LICENSED INVESTMENT PROFESSIONAL BEFORE MAKING ANY INVESTMENT DECISION. All material herein has been prepared by us based upon information believed to be reliable. The information contained herein is not guaranteed by us to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not always approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. We are not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed or mentioned herein. Beacon Equity Research has not been compensated by any of the companies covered in this release. It is the policy of Beacon Research and its affiliates to sell any stock received for services, which may cause the stock price to become depressed. Our affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. We may sell shares for less than the target price given in this opinion, or at any time following the issuance of this announcement. We will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Beacon Research and its owners undertake no obligation to update such statements.